Mimotope-based vaccines of Leishmania infantum antigens and their protective efficacy against visceral leishmaniasis.
about
Theranostic applications of phage display to control leishmaniasis: selection of biomarkers for serodiagnostics, vaccination, and immunotherapyAntigenicity, Immunogenicity and Protective Efficacy of Three Proteins Expressed in the Promastigote and Amastigote Stages of Leishmania infantum against Visceral LeishmaniasisPhage display as a promising approach for vaccine developmentA Leishmania-specific hypothetical protein expressed in both promastigote and amastigote stages of Leishmania infantum employed for the serodiagnosis of, and as a vaccine candidate against, visceral leishmaniasis.Strategies for Vaccine Design Using Phage Display-Derived Peptides.Evolution of phage display technology: from discovery to application.Application of phage peptide display technology for the study of food allergen epitopes.Prophylactic properties of a Leishmania-specific hypothetical protein in a murine model of visceral leishmaniasis.A recombinant chimeric protein composed of human and mice-specific CD4+ and CD8+ T-cell epitopes protects against visceral leishmaniasis.Cross-protective efficacy from a immunogen firstly identified in Leishmania infantum against tegumentary leishmaniasis.Selection strategy of phage-displayed immunogens based on an in vitro evaluation of the Th1 response of PBMCs and their potential use as a vaccine against Leishmania infantum infection.Peptide Vaccines for Leishmaniasis.
P2860
Q26796580-13750A57-7107-4E7B-963C-1E2FDF9436BEQ27318412-0ECA5BBD-2621-447D-8581-143A49FDF2FAQ28074592-EE08B68A-ABB9-4FF1-ADE2-C4BA1F1F2EC3Q35687444-24E1B6E8-E7D5-4134-AA8B-87A167551C0EQ35989226-7D96A23F-5B95-4798-B7E4-808D0D333846Q36183954-D1584F54-DC8A-4B89-9601-7E0C8FC9E4DCQ39044324-3356787E-8CD1-4E6F-BD48-567F54F1CBC1Q39156593-1A7371E4-A0D4-4548-994B-EFAF2E797E6AQ39220181-DE6491D9-068C-4356-A0AE-70D8F3C34EA7Q39220191-A4D6229E-E126-468D-ACC7-18F49540FAA2Q48560747-07048858-C002-4EFA-8174-6D0C17FB450DQ55210484-124AF661-9D16-417C-BA10-A9C40CFDCBD3
P2860
Mimotope-based vaccines of Leishmania infantum antigens and their protective efficacy against visceral leishmaniasis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Mimotope-based vaccines of Lei ...... gainst visceral leishmaniasis.
@ast
Mimotope-based vaccines of Lei ...... gainst visceral leishmaniasis.
@en
Mimotope-based vaccines of Lei ...... gainst visceral leishmaniasis.
@nl
type
label
Mimotope-based vaccines of Lei ...... gainst visceral leishmaniasis.
@ast
Mimotope-based vaccines of Lei ...... gainst visceral leishmaniasis.
@en
Mimotope-based vaccines of Lei ...... gainst visceral leishmaniasis.
@nl
prefLabel
Mimotope-based vaccines of Lei ...... gainst visceral leishmaniasis.
@ast
Mimotope-based vaccines of Lei ...... gainst visceral leishmaniasis.
@en
Mimotope-based vaccines of Lei ...... gainst visceral leishmaniasis.
@nl
P2093
P2860
P1433
P1476
Mimotope-based vaccines of Lei ...... against visceral leishmaniasis
@en
P2093
Ana Paula Fernandes
Carlos Alberto Pereira Tavares
Daniel Menezes-Souza
Eduardo Antonio Ferraz Coelho
Lourena Emanuele Costa
Manuel Soto
Maria Norma Melo
Mariana Costa Duarte
Mayara Ingrid Sousa Lima
Nathália Cristina de Jesus Pereira
P2860
P304
P356
10.1371/JOURNAL.PONE.0110014
P407
P577
2014-10-15T00:00:00Z